Fig. 5From: Effect of dipeptidyl-peptidase-4 inhibitors on C-reactive protein in patients with type 2 diabetes: a systematic review and meta-analysisAssessment of publication bias in the meta-analysis of studies reporting the impact of DPP-4i on serum concentrations of CRPBack to article page